Published in Nature on December 16, 2004
Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature (2010) 8.95
Confronting the scientific obstacles to global control of tuberculosis. J Clin Invest (2008) 4.41
Towards the optimal screening collection: a synthesis strategy. Angew Chem Int Ed Engl (2008) 3.53
Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell (2009) 3.42
Target profiling of small molecules by chemical proteomics. Nat Chem Biol (2009) 3.20
Privileged scaffolds for library design and drug discovery. Curr Opin Chem Biol (2010) 3.01
Identifying the proteins to which small-molecule probes and drugs bind in cells. Proc Natl Acad Sci U S A (2009) 2.94
TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res (2006) 2.26
Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol (2013) 2.01
Combination chemical genetics. Nat Chem Biol (2008) 1.98
Comprehensive mechanistic analysis of hits from high-throughput and docking screens against beta-lactamase. J Med Chem (2008) 1.81
Application of metal coordination chemistry to explore and manipulate cell biology. Chem Rev (2009) 1.56
ChemMine. A compound mining database for chemical genomics. Plant Physiol (2005) 1.56
Complementarity between a docking and a high-throughput screen in discovering new cruzain inhibitors. J Med Chem (2010) 1.54
Light-controlled modulation of gene expression by chemical optoepigenetic probes. Nat Chem Biol (2016) 1.49
Modulatory profiling identifies mechanisms of small molecule-induced cell death. Proc Natl Acad Sci U S A (2011) 1.45
Route to three-dimensional fragments using diversity-oriented synthesis. Proc Natl Acad Sci U S A (2011) 1.33
Structure-based discovery of inhibitors of the YycG histidine kinase: new chemical leads to combat Staphylococcus epidermidis infections. BMC Microbiol (2006) 1.27
Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation. Protein Sci (2006) 1.25
Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods. PLoS Comput Biol (2010) 1.24
Translation of DNA into a library of 13,000 synthetic small-molecule macrocycles suitable for in vitro selection. J Am Chem Soc (2008) 1.23
Induced pluripotent stem cells in cardiovascular drug discovery. Circ Res (2013) 1.22
A survey of yeast genomic assays for drug and target discovery. Pharmacol Ther (2010) 1.18
Computational drug discovery. Acta Pharmacol Sin (2012) 1.04
Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides. Chem Biol Drug Des (2010) 1.02
Role of natural product diversity in chemical biology. Curr Opin Chem Biol (2011) 1.01
Fully automated continuous flow synthesis of highly functionalized imidazo[1,2-a] heterocycles. Org Lett (2010) 0.98
Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication. Mol Syst Biol (2010) 0.97
Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein. J Biol Chem (2010) 0.94
Macromolecular scaffolds for immobilizing small molecule microarrays in label-free detection of protein-ligand interactions on solid support. Anal Chem (2009) 0.93
Selective kinase inhibition by exploiting differential pathway sensitivity. Chem Biol (2006) 0.91
Powerful partners: Arabidopsis and chemical genomics. Arabidopsis Book (2009) 0.91
Gold(I)-catalyzed coupling reactions for the synthesis of diverse small molecules using the build/couple/pair strategy. J Am Chem Soc (2009) 0.91
Synthetic plant defense elicitors. Front Plant Sci (2015) 0.88
Chemical microarray: a new tool for drug screening and discovery. Drug Discov Today (2006) 0.88
Calculations of protein-ligand binding entropy of relative and overall molecular motions. J Comput Aided Mol Des (2007) 0.88
Measuring binding of protein to gel-bound ligands using magnetic levitation. J Am Chem Soc (2012) 0.88
Heterocyclic N-Oxides - An Emerging Class of Therapeutic Agents. Curr Med Chem (2015) 0.87
Structure-based inhibition of protein-protein interactions. Eur J Med Chem (2014) 0.85
Deducing the mechanism of action of compounds identified in phenotypic screens by integrating their multiparametric profiles with a reference genetic screen. Nat Protoc (2014) 0.84
Integration of small-molecule discovery in academic biomedical research. Mt Sinai J Med (2010) 0.83
Chemical genetic approaches to probing cell death. Curr Opin Chem Biol (2006) 0.83
PROBING CANCER SIGNALING WITH RESONANT WAVEGUIDE GRATING BIOSENSORS. Expert Opin Drug Discov (2010) 0.82
Application of small organic molecules reveals cooperative TGFβ and BMP regulation of mesothelial cell behaviors. ACS Chem Biol (2011) 0.82
A combined bioinformatics and chemoinformatics approach for developing asymmetric bivalent AMPA receptor positive allosteric modulators as neuroprotective agents. ChemMedChem (2012) 0.82
TrixX: structure-based molecule indexing for large-scale virtual screening in sublinear time. J Comput Aided Mol Des (2007) 0.81
The yeast three-hybrid system as an experimental platform to identify proteins interacting with small signaling molecules in plant cells: potential and limitations. Front Plant Sci (2011) 0.80
Total synthesis and structure-activity relationship study of the potent cAMP signaling agonist (-)-alotaketal A. Org Biomol Chem (2013) 0.79
Small-molecule-based nanoassemblies as inducible nanoprobes for monitoring dynamic molecular interactions inside live cells. Angew Chem Int Ed Engl (2011) 0.79
Imaging-based chemical screening reveals activity-dependent neural differentiation of pluripotent stem cells. Elife (2013) 0.78
Identification of a small molecule that induces ATG5-and-cathepsin-l-dependent cell death and modulates polyglutamine toxicity. Exp Cell Res (2013) 0.78
Computational analysis of protein-protein interfaces involving an alpha helix: insights for terphenyl-like molecules binding. BMC Pharmacol Toxicol (2013) 0.78
Chemical genetics and its potential in cardiac stem cell therapy. Br J Pharmacol (2013) 0.77
Facile high-throughput forward chemical genetic screening by in situ monitoring of glucuronidase-based reporter gene expression in Arabidopsis thaliana. Front Plant Sci (2015) 0.77
The SCHOOL of nature: III. From mechanistic understanding to novel therapies. Self Nonself (2010) 0.77
A supramolecular dissociation strategy for protein sensing. Chem Commun (Camb) (2015) 0.77
Synthesis and in silico screening of a library of β-carboline-containing compounds. Beilstein J Org Chem (2012) 0.76
The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor. Cell Mol Life Sci (2010) 0.76
Development of tag-free photoprobes for studies aimed at identifying the target of novel Group A Streptococcus antivirulence agents. Bioorg Med Chem Lett (2014) 0.75
Development of a Multifunctional Benzophenone Linker for Peptide Stapling and Photoaffinity Labelling. Chembiochem (2016) 0.75
Diversity oriented synthesis and IKK inhibition of aminobenzimidazole tethered quinazoline-2,4-diones, thioxoquinazolin-4-ones, benzodiazepine-2,3,5-triones, isoxazoles and isoxazolines. Bioorg Med Chem Lett (2014) 0.75
An Algorithm to Identify Target-Selective Ligands - A Case Study of 5-HT7/5-HT1A Receptor Selectivity. PLoS One (2016) 0.75
Panspecies small-molecule disruptors of heterochromatin-mediated transcriptional gene silencing. Mol Cell Biol (2014) 0.75
Chemical genetics and strigolactone perception. F1000Res (2017) 0.75
The genetics of Caenorhabditis elegans. Genetics (1974) 102.14
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev (2001) 36.00
RNA interference. Nature (2002) 22.28
Global analysis of protein activities using proteome chips. Science (2001) 13.74
An information-intensive approach to the molecular pharmacology of cancer. Science (1997) 11.43
Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem (2004) 7.96
Target-oriented and diversity-oriented organic synthesis in drug discovery. Science (2000) 5.72
Microarrays of cells expressing defined cDNAs. Nature (2001) 5.05
DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54
A planning strategy for diversity-oriented synthesis. Angew Chem Int Ed Engl (2004) 4.21
Protein microarrays and proteomics. Nat Genet (2002) 4.17
Present and future of surface plasmon resonance biosensors. Anal Bioanal Chem (2003) 4.07
Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation. Nat Genet (2004) 3.84
Chemical genetics: ligand-based discovery of gene function. Nat Rev Genet (2000) 3.64
Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science (2003) 3.56
Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science (1998) 3.53
Identification and prediction of promiscuous aggregating inhibitors among known drugs. J Med Chem (2003) 3.44
Expanding small RNA interference. Nat Biotechnol (2002) 3.41
Self-assembling protein microarrays. Science (2004) 3.37
A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell (2003) 3.29
Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell (2003) 3.23
Automated docking to multiple target structures: incorporation of protein mobility and structural water heterogeneity in AutoDock. Proteins (2002) 2.70
Integration of virtual and high-throughput screening. Nat Rev Drug Discov (2002) 2.61
Pursuing the leadlikeness concept in pharmaceutical research. Curr Opin Chem Biol (2004) 2.36
Dissecting glucose signalling with diversity-oriented synthesis and small-molecule microarrays. Nature (2002) 2.34
Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins (1999) 2.30
Isothermal titration calorimetry and differential scanning calorimetry as complementary tools to investigate the energetics of biomolecular recognition. J Mol Recognit (2000) 2.22
A high-throughput cell migration assay using scratch wound healing, a comparison of image-based readout methods. BMC Biotechnol (2004) 2.08
Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg Med Chem (1998) 1.94
Generating diverse skeletons of small molecules combinatorially. Science (2003) 1.87
Profiling protein function with small molecule microarrays. Proc Natl Acad Sci U S A (2002) 1.77
Inducible gene expression and protein translocation using nontoxic ligands identified by a mammalian three-hybrid screen. Proc Natl Acad Sci U S A (1997) 1.66
Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjug Chem (2001) 1.65
Diversity-oriented synthesis; a challenge for synthetic chemists. Org Biomol Chem (2003) 1.51
Integrating virtual screening in lead discovery. Curr Opin Chem Biol (2004) 1.48
A cell-based screen for drugs to treat Huntington's disease. Neurobiol Dis (2004) 1.45
Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism. Chem Biol (2004) 1.45
Small molecule affinity fingerprinting. A tool for enzyme family subclassification, target identification, and inhibitor design. Chem Biol (2002) 1.42
A protein-domain microarray identifies novel protein-protein interactions. Biochem J (2002) 1.42
Discovery of a potent and selective protein kinase CK2 inhibitor by high-throughput docking. J Med Chem (2003) 1.30
Biological mechanism profiling using an annotated compound library. Chem Biol (2003) 1.23
A cell system with targeted disruption of the SMN gene: functional conservation of the SMN protein and dependence of Gemin2 on SMN. J Biol Chem (2000) 1.21
Measuring protein-protein interactions. Curr Opin Struct Biol (1998) 1.15
Twenty-five years of cell cycle genetics. Genetics (1991) 1.14
Development and application of fluorescence polarization assays in drug discovery. Comb Chem High Throughput Screen (2003) 1.13
Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition. J Med Chem (2001) 1.09
Confirming specificity of RNAi in mammalian cells. Sci STKE (2002) 1.07
Frontiers in chemical genetics. Trends Biotechnol (2000) 0.99
Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries. J Med Chem (2004) 0.90
Pathway development and pilot library realization in diversity-oriented synthesis: exploring Ferrier and Pauson-Khand reactions on a glycal template. Chem Biol (2002) 0.89
Chemical genetic screening approaches to neurobiology. Neuron (2002) 0.88
Label-free parallel screening of combinatorial triazine libraries using reflectometric interference spectroscopy. Anal Chem (2002) 0.86
Strategies for designing GPCR-focused libraries and screening sets. Curr Opin Drug Discov Devel (2004) 0.85
Finding Cinderella after the ball: a three-hybrid approach to drug target identification. Chem Biol (2004) 0.85
Global analysis of large-scale chemical and biological experiments. Curr Opin Drug Discov Devel (2002) 0.85
Recent developments in analytical and functional protein microarrays. Curr Opin Mol Ther (2003) 0.84
Fluorescence correlation spectroscopy: molecular complexing in solution and in living cells. Methods Cell Biol (2003) 0.84
Recent advances in NMR: expanding its role in rational drug design. Curr Med Chem (2001) 0.83
Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg Med Chem Lett (2003) 0.82
Design of diversity and focused combinatorial libraries in drug discovery. Curr Opin Drug Discov Devel (2004) 0.81
Physical and spectroscopic methods for the evaluation of the interactions of antimitotic agents with tubulin. Pharmacol Ther (1991) 0.80
Chemical microarrays, fragment diversity, label-free imaging by plasmon resonance--a chemical genomics approach. J Cell Biochem Suppl (2002) 0.80
Development of an assay for label-free high-throughput screening of thrombin inhibitors by use of reflectometric interference spectroscopy. Anal Bioanal Chem (2001) 0.80
Early discovery drug screening using mass spectrometry. Curr Top Med Chem (2002) 0.80
Modern drug development from traditional medicinal plants using radioligand receptor-binding assays. Med Res Rev (1998) 0.80
Protein affinity map of chemical space. J Chromatogr B Biomed Sci Appl (1998) 0.80
Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases. J Mol Graph Model (1999) 0.79
Chemical genomics as an emerging paradigm for postgenomic drug discovery. Pharmacogenomics (2003) 0.79
A solid-phase, library synthesis of natural-product-like derivatives from an enantiomerically pure tetrahydroquinoline scaffold. J Comb Chem (2004) 0.79
A solid phase library synthesis of hydroxyindoline-derived tricyclic derivatives by Mitsunobu approach. J Comb Chem (2004) 0.79
Fluorescence imaging and engineered biosensors: functional and activity-based sensing using high content screening. Ann N Y Acad Sci (2002) 0.78
To affinity and beyond. Nature (2003) 0.78